143 related articles for article (PubMed ID: 10828801)
1. Prognostic value of p53, proliferating cell nuclear antigen, and Ki-67 expression in undifferentiated nasopharyngeal carcinomas.
Genç E; Hoşal AS; Gedikoğlu G; Ozyar E; Sözeri B
Otolaryngol Head Neck Surg; 2000 Jun; 122(6):868-73. PubMed ID: 10828801
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas.
Tsai ST; Jin YT; Leung HW; Wang ST; Tsao CJ; Su IJ
Anticancer Res; 1998; 18(4B):2849-54. PubMed ID: 9713473
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
[TBL] [Abstract][Full Text] [Related]
5. Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma.
Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
Am J Otolaryngol; 2006; 27(2):101-5. PubMed ID: 16500472
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
[TBL] [Abstract][Full Text] [Related]
7. [Study on expression and relationship between proliferating cell nuclear antigen and p53 oncoprotein in nasopharyngeal carcinoma].
Cheng Q; Wei J; Huang X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):643-5. PubMed ID: 16248462
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of p53 index and expression of proliferating cell nuclear antigen and Ki-67 in gastric cancer.
Setälä L; Kosma VM; Lipponen P; Naukkarinen A; Nordling S; Hollmén S; Eskelinen M; Syrjänen K; Alhava E
J Cancer Res Clin Oncol; 1998; 124(9):497-502. PubMed ID: 9808424
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
[TBL] [Abstract][Full Text] [Related]
11. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].
Sittel C; Ruiz S; Kvasnicka HM; Volling P; Jungehülsing M; Eckel HE
Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
14. PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma.
Lumachi F; Ermani M; Marino F; Iacobone M; Baldessin M; Cappuzzo G; Zanella S; Favia G
Anticancer Res; 2006; 26(2A):1305-8. PubMed ID: 16619538
[TBL] [Abstract][Full Text] [Related]
15. Expression of bcl-2-, p53, and Ki-67 and outcome of patients with primary nasopharyngeal carcinomas following DNA-damaging treatment.
Masuda M; Shinokuma A; Hirakawa N; Nakashima T; Komiyama S
Head Neck; 1998 Oct; 20(7):640-4. PubMed ID: 9744466
[TBL] [Abstract][Full Text] [Related]
16. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
17. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
[TBL] [Abstract][Full Text] [Related]
19. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]